Sysmex Inostics

All stories by Sysmex

Other Authors

Press Release

Sysmex Inostics’ Colorectal Cancer Blood-Based OncoBEAM™ RAS CE-IVD Test Shows Concordance with Standard of Care Tissue-Based RAS Testing

Aug 5, 2020 6:00:40 AM |
3 min read
Press Release

Sysmex Inostics and Oxford Gene Technology plasma and tissue sequencing demonstrate clearance of ctDNA correlates w/ pathologic complete response in breast cancer patients during neoadjuvant treatment

Jan 28, 2020 6:15:00 AM |
2 min read
Press Release

Sysmex Inostics Tissue-independent Liquid Biopsy for Early Stage Breast Cancer Mutation Characterization and Monitoring Using Ultra-sensitive SafeSEQ Technology

Dec 16, 2019 6:44:37 AM |
3 min read
Press Release

Sysmex Inostics launches two NGS-based liquid biopsy panels for cancer therapy drug development

Sep 27, 2019 6:05:00 AM |
3 min read
Press Release

Sysmex Inostics publishes first feasibility study of NGS-based liquid biopsy to complement early breast cancer screening by imaging

Sep 4, 2019 6:30:46 AM |
2 min read
Press Release

Sysmex obtains Japanese manufacturing and marketing approval for the first blood-based RAS mutation testing for colorectal cancer

Aug 2, 2019 8:20:26 AM |
2 min read
Germany

Sysmex Inostics OncoBEAM™-EGFR Digital PCR Liquid Biopsy Demonstrates Two-fold Higher Detection of p.T790M Mutations in 183 NSCLC Patients in Comparison Study

May 30, 2019 1:51:00 PM |
2 min read
Germany

Sysmex Inostics' SafeSEQ ER+/HER2- Breast Cancer Panel Demonstrates Equivalent Sensitivity to OncoBEAM™ Enhanced Digital PCR Technology for Detection of Mutations in Circulating Tumor DNA

May 28, 2019 1:45:00 PM |
3 min read
Germany

Sysmex Inostics´ OncoBEAM™ demonstrates clinical validity and superior performance versus pan-cancer NGS for blood-based mutation detection for hepatocellular carcinoma

Feb 25, 2019 1:22:00 PM |
3 min read
Germany

Sysmex Inostics´ OncoBEAM™ circulating tumor DNA technology demonstrates superior response prediction for advanced pancreatic cancer over standard-of-care protein biomarkers

Nov 5, 2018 1:26:00 PM |
4 min read

|
1 min read

|
1 min read

Information in accordance with Art. 13 GDPR: https://www.sysmex-inostics.com/data

Germany: Sysmex Inostics GmbH, Falkenried 88, D-20251 Hamburg, Germany. +49 40- 325907-0

United States: Sysmex Inostics, Inc., 1812 Ashland Ave Suite 500, Baltimore, Maryland 21205, USA.   +1-855-BEAM-DNA (232-6362)

Japan: Sysmex Corporation, 1-5-1 Wakinohama-Kaigandori, Chuo-ku, Kobe 651-0073, Japan.   +81 78 265-0500
Copyright © Sysmex Inostics, All Rights Reserved.